Legal Update, Hill Day 2020
In recent weeks, three drug manufacturers have taken unprecedented actions that threaten covered entity participation in the 340B Discount Drug Pricing Program (340B Program).
Legal Update, June 2020
Legal Update Program Income Rules Still Apply During a Public Health Emergency By Elizabeth 'Issie' Karan The COVID-19 epidemic has placed unprecedented challenges on the U.S. economy and healthcare system. In the coming weeks and months, many institutions and organizations may find themselves in unexpected positions, financially and otherwise. As hemophilia treatment centers (HTCs) and […]
Legal Update, May 2020
Legal Update 340B Program Flexibilities During COVID-19 Pandemic By Elizabeth 'Issie' Karan Hemophilia Treatment Centers (HTCs) may benefit from relaxation of 340B Drug Pricing Program policies during the COVID-19 pandemic. The Office of Pharmacy Affairs (OPA) which oversees the 340B Program developed a website with resources and frequently asked questions (OPA FAQs) related to the […]
Legal Update, April 2020
Helping Patients Impacted by COVID-19 through Chapters
Legal Update, March 2020
Why and How HTCs Can Use Referral Arrangements in the 340B Program
Legal Update, April 2019
ยท Roadmap for Compliant Expenditures of Federal Funds: Highway to the Danger Zone!